Survivin: a target from brain cancer to neurodegenerative disease

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Apoptosis contributes to neuronal death in neurodegenerative disorders such as multiple sclerosis, Parkinson's disease, and sciatic nerve injury.
• Current neuroprotective strategies targeting caspases have unclear clinical benefits.
• Inhibitors of Apoptosis (IAP) family proteins offer alternative neuroprotective mechanisms.

Purpose of the Study:

• To explore novel therapeutic strategies for protecting neurons from apoptosis using IAP family members.
• To review the specific roles of survivin, an IAP family member, in apoptosis inhibition and cell division.
• To identify survivin as a potential therapeutic target for neurodegenerative diseases.

Main Methods:

• Literature review of studies on apoptosis, neurodegeneration, and IAP proteins.
• Analysis of survivin's dual role in inhibiting apoptosis and regulating mitosis.
• Exploration of therapeutic potential based on survivin's functions.

Main Results:

• Survivin, an IAP member, plays a critical role in both inhibiting apoptosis and regulating cell division (mitosis).
• Targeting survivin presents a unique therapeutic opportunity due to its multifaceted functions.
• The dual role of survivin suggests its potential as a novel target for neuroprotection.

Conclusions:

• Survivin's involvement in both apoptosis and cell division offers a promising therapeutic window for neurodegenerative diseases.
• Targeting survivin represents a novel strategy distinct from caspase inhibitors for neuronal protection.
• Further research into survivin modulation could lead to new treatments for conditions involving neuronal loss.